Primary Record
CLEMASTINE FUMARATE
- In stock
- 3,547 g
- Purity
- 98.1 %
- CAS
- 14976-57-9
Compound Identifiers & Properties
- CAS
- 14976-57-9
- PubChem CID
- 5281069
- SMILES
- C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C.C(=C/C(=O)O)\C(=O)O
- Canonical SMILES
- CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O
Names & Synonyms
- CLEMASTINE FUMARATE
- Agasten
- Tavist
- clemastine
- Mecloprodine
- Aloginan
- Xolamin
- Fuluminol
- Kinotomin
- Marsthine
- Masletine
- Alphamin
- Anhistan
- Clemanil
- Inbestan
- Lacretin
- Lecasol
- Piloral
- Reconin
- Tavegil
- Trabest
- 14976-57-9
- Maikohis
- Mallermin-F
- Tavegyl
- Telgin-G
- Tavist-1
- Clemastina
- Clemastinum
- Mecloprodin
- Meclastin
- Clemastine hydrogen fumarate
- Mixture Name
- Meclastine fumarate
- Clemastine (fumarate)
- Prestwick_680
- Meclastine hydrogen fumarate
- Topcare dayhist allergy
- Clemastine Fumarate?
- HS-592;Meclastine
- Contac 12 Hour Allergy
- AC1NQXZB
- TAVIST D
- TAVIST-D
- Clemastine fumarate CRS
- Clemastine fumarate salt
- clemastine; fumaric acid
- RefChem:56360
- C25H30ClNO5
- Clemastine [USAN:BAN]
- Clemastinum [INN-Latin]
- Clemastina [INN-Spanish]
- DTXSID6047785
- C21H26ClNO
- HSDB 6507
- UNII-19259EGQ3D
- C21H26ClNO.C4H4O4
- CHEBI:3739
- 19259EGQ3D
- UNII-95QN29S1ID
- MFCD00137486
- SCHEMBL33403
- DTXCID6027765
- Tavist Allergy/Sinus/Headache
- Clemastine [USAN:INN:BAN]
- SPECTRUM1500191
- EINECS 239-055-2
- PMGQWSIVQFOFOQ-YKVZVUFRSA-N
- HY-B0298AR
- Tavist;Xolamin;Agasten;Aloginan
- C21-H26-Cl-N-O
- CHEMBL1200795
- Clemastine for system suitability
- HMS500O07
- HY-B0298A
- CLEMASTINE FUMARATE [JAN]
- Clemastine (fumarate) (Standard)
- Clemastine fumarate [USAN:BAN:JAN]
- CLEMASTINE FUMARATE [HSDB]
- CLEMASTINE FUMARATE [USAN]
- HMS1568N14
- HMS1920O13
- HMS2091E20
- HMS2095N14
- HMS3267L12
- HMS3412B19
- HMS3676B19
- HMS3712N14
- HMS3884K12
- Pharmakon1600-01500191
- CLEMASTINE FUMARATE [VANDF]
- BCP27945
- CLEMASTINE FUMARATE [MART.]
- MSK10900
- Tox21_110574
- CCG-40028
- CLEMASTINE FUMARATE [USP-RS]
- CLEMASTINE FUMARATE [WHO-DD]
- HS 592
- NP3342
- NSC756685
- s1847
- 14976-57-9 (FUMARATE)
- Clemastine for system suitability CRS
- (R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine fumarate
- AKOS015896237
- AKOS037643271
- Clemastine fumarate [USAN:USP:BAN:JAN]
- Tox21_110574_1
- AC-1338
- CID5281069
- CS-2331
- CS-O-06237
- NSC-756685
- Clemastine fumarate - Bio-X trade mark
- CLEMASTINE FUMARATE [ORANGE BOOK]
- CLEMASTINE HYDROGEN FUMARATE [MI]
- NCGC00016710-01
- NCGC00016710-05
- NCGC00180903-01
- NCGC00180903-02
- AS-12093
- BC164321
- BC206422
- C21-H26-Cl-N-O.C4-H4-O4
- CLEMASTINE FUMARATE [EP MONOGRAPH]
- CLEMASTINE FUMARATE [USP MONOGRAPH]
- Clemastine fumarate salt, >=98% (HPLC)
- HS-592 (fumarate);Meclastine (fumarate)
- AB2000329
- CAS-14976-57-9
- LS-137507
- B1558
- FT-0656312
- ST24046356
- SW196835-3
- TAVIST-D COMPONENT CLEMASTINE FUMARATE
- A10226
- H10994
- K-4763
- 976C579
- A808955
- F859378
- SR-05000001590
- (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine fumarate (1:1)
- I06-2109
- SR-05000001590-1
- (+)-2-(2-((p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl pyrrolidine fumarate
- Q27106180
- 14976-57-9, 15686-51-8 (base)
- 15686-51-8
- Pyrrolidine,2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-,(2E)-2-butenedioate (1:1)
- (2E)-but-2-enedioic acid; (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine
- Pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (R-(R*,R*))-, (E)-2-butenedioate (1:1)
- 2-(2-(4-Chlor-alpha-methylbenzhydryloxy)ethyl)-1-methylpyrrolidin
- Clemastine fumarate, European Pharmacopoeia (EP) Reference Standard
- (R-(R*,R*))-2-(2-(1-(p-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidinium hydrogen fumarate
- Clemastine fumarate, United States Pharmacopeia (USP) Reference Standard
- Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-, fumarate (1:1)
- (+)-2-[2-[(p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy]ethyl]-1-methylpyrrolidine
- (2R)-2-(2-((1R)-1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine monofumarate
- (2R)-2-[2-[(1R)-1-(4-Chlor-ophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
- (2R)-2-[2-[(1R)-1-(4-Chlorophenylethoxy]ethyl]-1-methyl-2-pyrrolidine fumarate
- (R)-2-[2-[(R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine fumarate
- Clemastine for system suitability, European Pharmacopoeia (EP) Reference Standard
- Pirrolidina, 2-[2-[(1R)-1-(4-clorofenil)-1-fenilethoxi] etil]-1-metil-, (2R)-
- Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-
- Pyrrolidine, 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, [R-(R*,R*)]-
- (+)-(2R)-2-(2-(((R)-P-CHLORO-.ALPHA.-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYL)-1-METHYLPYRROLIDINE FUMARATE (1:1)
- (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
- (2E)-But-2-enedioic acid--(2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine (1/1)
- (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenyl-ethoxy]ethyl]-1-methyl-pyrrolidine;fumaric acid
- (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidin-1-ium;(E)-4-hydroxy-4-oxobut-2-enoate
- (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine (2E)-but-2-enedioate
- (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidinium (2E)-3-carboxyprop-2-enoate
- (E)-but-2-enedioic acid; (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
- (E)-but-2-enedioic acid;(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
- [R-(R*,R*)]-2-[2-[1-(p-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidinium hydrogen fumarate
- Clemastine fumarate; (2R)-2-[2-[(R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine (E)-butenedioate; Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-, (2E)-2-butenedioate (1:1); Clemastine Fumarate; Pyrrolidine, 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, [R-(R*,R*)]-, (E)-2-butenedioate (1:1); Agasten; Aloginan; Alphamin; Anhistan; Bravegyl; Clemastine hydrogen fumarate; Fuluminol; HS 592; Inbestan; Kinotomin; Lacretin; Lecasol; Maikohis; Mallermin F; Marsthine; Masletine; Meclastine fumarate; Mecloprodine; Piloral; Reconin; Tavegil; Tavegyl; Tavist; Telgin; Telgin G; Trabest; Xolamin; Pyrrolidine, 2-[2-[(p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy]ethyl]-1-methyl-, (+)-, fumarate (1:1) (8CI); (+)-2-[2-[(p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy]ethyl]-1-methylpyrrolidine fumarate
- Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-,fumarate (1:1)
- Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-, (2E)-2-butenedioate (1:1)
- Pyrrolidine, 2-[2-[(p-chloro-.alpha.-methyl-.alpha.-phenylbenzyl)oxy]ethyl]-1-methyl-, ()-
- Pyrrolidine, 2-[2-[(p-chloro-.alpha.-methyl-.alpha.-phenylbenzyl)oxy]ethyl]-1-methyl-, ()-, fumarate (1:1)
- Pyrrolidine, 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, [R-(R*,R*)]-, (E)-2-butenedioate (1:1)